ZEAL Zealand Pharma A/S ADRs

Zealand Pharma A/S is a biotech company. It is engaged in the business of turning peptides into medicines. The Company has proprietary pipeline of novel investigational medicines and a mature portfolio of products. This is an ADR of a company whose stock trades outside of the U.S. as the symbol DC:ZEAL.

As of 06/28/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Denmark
Country of incorporation:  Denmark
IPO date:  08/09/2017
Outstanding shares:  46,526,510
Average volume:  1,065
Market cap:   $649,277,447
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      B0SDJB4
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.65
PS ratio:   0.00
Return on equity:   -140.74%
Net income %:   -384.42%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy